2007
Cost‐effectiveness of prize‐based contingency management in methadone maintenance treatment programs
Sindelar JL, Olmstead TA, Peirce JM. Cost‐effectiveness of prize‐based contingency management in methadone maintenance treatment programs. Addiction 2007, 102: 1463-1471. PMID: 17645428, PMCID: PMC3072844, DOI: 10.1111/j.1360-0443.2007.01913.x.Peer-Reviewed Original ResearchConceptsPrize-based contingency managementUsual careContingency managementStimulant-negative urine samplesUrine samplesNational Drug Abuse Treatment Clinical Trials NetworkTreatment programMethadone maintenance treatment programIncremental costBaseline urine samplesMulti-site clinical trialMaintenance treatment programMethadone maintenance clinicsClinical Trials NetworkCommunity treatment programsCost-effectiveness studiesCost of treatmentCost-effectiveness analysisPresence of stimulantsCM conditionClinical trialsCommunity clinicsMaintenance clinicsEffectiveness trialTreatment outcomesThe cost‐effectiveness of four treatments for marijuana dependence
Olmstead TA, Sindelar JL, Easton CJ, Carroll KM. The cost‐effectiveness of four treatments for marijuana dependence. Addiction 2007, 102: 1443-1453. PMID: 17645430, PMCID: PMC2398724, DOI: 10.1111/j.1360-0443.2007.01909.x.Peer-Reviewed Original ResearchConceptsMET/CBTDrug counselingContingency managementPatient outcomesYoung adultsEffective treatmentMarijuana dependenceAcceptability curvesIncremental cost-effectiveness ratioRandomized clinical trialsCost of therapyPatient outcome measuresCost-effective dependsCost-effectiveness ratioSubstance abuse clinicsCost-effective treatmentCM procedureClinical trialsOutcome measuresUrine specimenUrine specimensAdditional weeksAdditional studiesMarijuana abstinenceLonger duration
2006
Cost-effectiveness of prize-based incentives for stimulant abusers in outpatient psychosocial treatment programs
Olmstead TA, Sindelar JL, Petry NM. Cost-effectiveness of prize-based incentives for stimulant abusers in outpatient psychosocial treatment programs. Drug And Alcohol Dependence 2006, 87: 175-182. PMID: 16971054, PMCID: PMC1950254, DOI: 10.1016/j.drugalcdep.2006.08.012.Peer-Reviewed Original ResearchConceptsUsual careStimulant abusersClinical trialsPatient outcomesNational Drug Abuse Treatment Clinical Trials NetworkDrug abuse treatment clinicsAbstinence-based incentivesIncremental cost-effectiveness ratioUsual care groupPrimary patient outcomeRandomized clinical trialsClinical Trials NetworkPsychosocial treatment programCost-effectiveness ratioCost-effectiveness analysisCare groupTreatment clinicsStimulant abstinenceAcceptability curvesAbstinence timeTreatment programTrials NetworkIncremental costCareIncentive group
2004
Value to smokers of improved cessation products: Evidence from a willingness-to-pay survey
Busch S, Falba T, Duchovny N, Jofre-Bonet M, O'Malley S, Sindelar J. Value to smokers of improved cessation products: Evidence from a willingness-to-pay survey. Nicotine & Tobacco Research 2004, 6: 631-639. PMID: 15370159, DOI: 10.1080/14622200410001727885.Peer-Reviewed Original ResearchConceptsSmoking cessation productsSmoking cessationCessation productsCessation treatmentEffective smoking cessation treatmentsWeight gainTobacco cessation treatmentSmoking cessation treatmentPresent studyClinical trialsEffective treatmentBaseline surveyCessationTreatmentNew HavenMedicationsSmokersTrialsCost effectiveness of disulfiram Treating cocaine use in methadone-maintained patients
Jofre-Bonet M, Sindelar JL, Petrakis IL, Nich C, Frankforter T, Rounsaville BJ, Carroll KM. Cost effectiveness of disulfiram Treating cocaine use in methadone-maintained patients. Journal Of Substance Use And Addiction Treatment 2004, 26: 225-232. PMID: 15063917, PMCID: PMC3662046, DOI: 10.1016/s0740-5472(04)00004-2.Peer-Reviewed Original ResearchConceptsMethadone treatmentClinical trialsCocaine useDouble-blind clinical trialCocaine dependenceStandard methadone treatmentBlind clinical trialMethadone-maintained patientsRandomized clinical trialsOpioid-dependent subjectsMethadone-maintained opiate addictsStandard treatmentOutcome measuresOpioid addictsPromising treatmentOpiate addictsIncremental costDisulfiramAdditional treatmentNumber of daysTrialsTreatmentCost effectivenessEconomic evaluationAddicts